image

Allerway Meltaway 5 is indicated in adults and children from 6 years of age for the relief of symptoms associated with seasonal or perennial allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives).1 Allerway Meltaway 5 is an orodispersible tablet for all-day allergy relief on the go.*1

Ask your pharmacist about over-the-counter allergy relief options from Dr. Reddy’s.

Shop at your nearest pharmacy or these leading retailers:

Clicks
Dis-Chem
image

Orodispersible tablets provide convenient administration for on-the-go allergy relief.1,3 

Advantages of orodispersibles:

  • Dissolves in your mouth; with or without water1
  • Accurate dosing3
  • Easy administration for children (from 6 years of age) unable to swallow1,3,4
  • Liquid medication in the form of solid preparation3
  • Higher stability compared to liquid dosage form4

Orodispersible tablets are regarded as superior dosage forms in terms of acceptability and safety of administration.4

image
image
image
image
image

Allerway Meltaway 5 Digital Video

*In adults and children from 6 years of age. 1 Hay fever is seasonal or present throughout the year7
†Of levocetirizine compared to cetirizine, fexofenadine and desloratadine2
After 4 weeks provided by levocetirizine 5 mg daily compared to cetirizine 10 mg once daily (57.7%)6
§Allerway Meltaway 5 orodispersible tablet should be placed on the tongue and sucked, not chewed, until complete disintegration. The resulting suspension has to be swallowed with saliva1
Approved Allerway Meltaway 5 Digital Video - R1375754-ZA-CO-21082025-0928

References: 1. Allerway Meltaway 5 [Professional Information]. Sandton, South Africa: Dr. Reddy’s Laboratories (Pty) Ltd; 2024. 2. Walter Canonica G, Blaiss M. Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: A Review of the Evidence. World Allergy Organ. 2011; 4(2):47-53. 3. Anupam R. Orodispersible Tablets: A Review. Asian J Pharm Clin Res. 2016; 9(1):19-26. 4. Cornila A, Iurian S, Tomuta I, et al. Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations. Pharmaceutics. 2022; 14(8):1-28. 5. Based on internal analysis by Dr. Reddy’s Laboratories (Pty) Ltd. using data from the following source: IQVIA TPM MAT Sept 2023 ATC3 R6A- Levocetirizine market measured in Units, reflecting estimates of real world activity. Copyright IQVIA. All rights reserved. 6. Seema R, Gupta MC, Verma P, Singh D. A Comparative Study of Clinical Efficacy and Tolerability of Second Generation (Cetirizine) and Third Generation (Levocetirizine) Antihistaminics in Seasonal Allergic Rhinitis. J Adv Res Biol Sci. 2012; 4(2):152-155. 7. Cleveland Clinic. Allergic Rhinitis (Hay Fever). Available at: https://my.clevelandclinic.org/health/diseases/8622-allergic-rhinitis-hay-fever. [Accessed 11/09/2023].

S1 ALLERWAY MELTAWAY 5. Reg. No.: 55/5.7.1/0712. Each orodispersible tablet contains levocetirizine dihydrochloride 5 mg. Contains sugar (104,00 mg lactose monohydrate per tablet, 67,15 mg mannitol per tablet and 3,95 mg sorbitol per tablet). Contains 5,00 mg aspartame per tablet. For full prescribing information please refer to the professional information approved by the Medicines Regulatory Authority.

Dr. Reddy’s Laboratories (Pty) Ltd., Block C, Woodmead North Office Park, 54 Maxwell Drive, Woodmead, Sandton, Gauteng, 2191. Reg.No.: 2002/014163/07. Tel: +27 11 324 2100. www.drreddys.co.za. R1375720-ZA-CO-21082025-0924